ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

ProPhase Labs Inc.

Prophase Labs ( ($PRPH) ) has released its Q3 earnings. Here is a breakdown of the information Prophase Labs presented to its investors. ProPhase L...

ProPhase Labs Reports Q3 Loss Amid Strategic Shifts

An update from Prophase Labs ( ($PRPH) ) is now available. On November 19, 2025, ProPhase Labs announced its strategic initiatives, including M&A d...

Prophase Labs Unveils Strategic Initiatives and Partnerships

Prophase Labs ( ($PRPH) ) has released a notification of late filing. ProPhase Labs, Inc. has announced a delay in filing its Form 10-Q (Quarter Re...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRPH	$0.19	-1.46%	1.28M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRPH	$0.19	-1.5%	1.28M
3
4
5
6

PRPH

PRPH

Get ProPhase Labs Inc. Data in Excel

Get ProPhase Labs Inc. Data in Excel